Editorial
Childhood Glaucoma
P. S. Mahar
Pak J Ophthalmol 2018, Vol. 34, No. 4
. . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . .. . .. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . .
Childhood glaucoma is a heterogeneous
cluster of disorders occurring in early years of life. According to the
American Academy of Ophthalmology1, congenital glaucoma is present
at birth or diagnosed up to 12 months of life. Infantile glaucoma is present
from 1 year to 3 years and after 3 years onwards, it is termed as juvenile
glaucoma. This division however can be arbitrary in our country where child is
brought often too late for clinical advice.
Most of the pediatric glaucoma have no specific
identifiable cause and are considered as primary glaucoma. However, when
glaucoma is associated with some specific disease, it is called as secondary
glaucoma. Some of the disorders associated with childhood glaucoma include
Axenfeld – Rieger syndrome, Sturge-Weber syndrome, Aniridia and
Neurofibromatosis. The chronic use of topical steroids, trauma and cataract
surgery remain the other associated factors.
About 10% of primary congenital/infantile
glaucoma are inherited with specific gene mutation. The secondary glaucoma
associated with neurofibromatosis and Aniridia are inherited by autosomal gene,
which can be passed on to 50% of affected children2.
The prevalence of primary congenital
glaucoma (PCG) is not known in this country but it occurs in about 1:10,000
live births in USA3. In Saudi Arabia PCG is estimated to have a
prevalence up to 10 times higher than in USA occurring in 1:2500 to 3000 live
births4.
The condition is usually managed
surgically. The surgical techniques are designed to eliminate the resistance of
aqueous outflow created by the structural abnormalities in the anterior chamber
angle. These congenital changes include presence of non-permeable Barkan’s
membrane covering the trabecular meshwork and anterior insertion of ciliary
body and Iris, overlapping the trabecular meshwork5,6.
Childhood glaucoma poses a huge diagnostic challenge,
as young children are uncooperative and difficult to examine in routine setup.
The Intraocular pressure (IOP) reading can be difficult to obtain even under
sedation as these sedating agents can influence the readings of IOP so these
children should be examined and referred to a special unit equipped with handheld
tonometer, portable slit lamp and anesthetic facilities.
Managing childhood glaucoma is one of difficult
tasks for glaucoma specialist. The goal of treatment should be better control
of IOP and preservation of vision. Glaucoma surgery remains the eventual
treatment. Anti-glaucoma drops are used to stabilize the IOP until surgery is
scheduled. Because of serious side effects of medical therapy in the young age,
topical drops are carefully chosen. Usually Beta-blockers and Alpha agonists
are avoided because of their potential harmful side effects.
Broadly, the surgical treatment is divided
into 3 categories.
1.
Angle surgeries like Goniotomy
and Trabeculotomy are meant to enhance the aqueous outflow pathway. Goniotomy
is usually preferred if cornea is clear. In case of hazy cornea when angle
structures cannot be visualized, trabeculotomy is the procedure of choice. It
is generally accepted that success rate of these 2 procedures is similar with
same degree of disease severety7,8,9. However, advocates of Goniotomy
argue in its favor when considering the long-term effect especially for future
glaucoma surgery such as trabeculectomy as conjunctiva and sclera remains
untouched, increasing the future success of drainage surgery. With the
availability of anti-fibrotic Mitomycin C (MMC), this may not be the case10.
Recently 360 degrees canaloplasty is taking momentum, which can be performed
from outside or inside the eye. The success rate of circumferential 360 degrees
trabeculotomy in eyes with PCG varies from 77% – 92% after 1 – 4 years11,12,13.
2.
The second set of surgical
category is to create external outflow like trabeculectomy or placement of
glaucoma drainage devices (GDD). The result of trabeculectomy in children has
been poor but with the advent of adjunctive use of MMC, surgical outcome has
improved. Our results with MMC augmented trabeculectomy in PCG has shown that
58% of children up to 3 years of age maintained the IOP of less than 15 mm Hg
at the end of 1 year follow-up14. Molteno first published his
results of use of GDD in children in 197315. Since then several
researchers have used Ahmed Glaucoma Valve and Baerveldt implant in children.
At 1 to 2 years follow-up, many workers have reported a success rate of 80% but
this has reduced to 50% in long-term follow-up16,17. If one looks at
the literature, there is no superiority of one device over other. However, Baerveldt
implant may provide slight better long-term IOP control but Ahmed implant has
shown lesser complications18,19.
3.
The third category is
procedures causing reduction of aqueous production. This includes cyclo-destructive
procedures usually carried out with trans-scleral diode laser of 810 nm. This
procedure is traditionally reserved for refractory cases where routine surgery
has failed. However, accurate laser application in big eyeball with distorted
landmarks can be extremely difficult. Endoscopic diode laser can be used in
these cases but its use in phakic eyes remains controversial.
The best surgical procedures in childhood glaucoma should consider
age of the patient, underlying cause of glaucoma, associated ocular factors,
any previous ocular surgery, and extent of visual damage and above all surgical
expertise of treating specialist and facilities available locally.
The diagnosis of
childhood glaucoma not only affects the child and parents emotionally but also
can hinder child’s education in long term and also can be burden on the family
to finance multiple surgeries and hospital costs. In these cases, it may be
prudent for primary physician to refer such child to an institute where these
factors can be addressed.
Author’s Affiliation
Prof. Dr. P.S. Mahar
FRCS, FRCOphth
Professor of
Ophthalmology & Dean
Isra Postgraduate
Institute of Ophthalmology
Consultant Eye Surgeon,
Director Glaucoma Service
Aga Khan University
Hospital, Karachi.
Financial Interest: None.
Conflict of Interest: None.
REFERENCES
1.
American Academy of Ophthalmology, basic and clinical sciences
course. Section 6. Pediatric
Ophthalmology & Strabismus, 2009 – 2010.
2.
Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in
Cytochrome PS501B1 (CYP1B1) as the principal cause of primary congenital
glaucoma (Buphthalmos) in families linked to the GLC3A locus on Chromosome
2P21. Human Mol Genetics, 1997; 6 (4): 641-647.
3.
Hoskins HD Jr, Shaffer RN, Hetherington J. Anatomical classification of developmental glaucomas. Arch
Ophthalmol. 1984; 102: 1331-1337.
4.
Malik R, Khandekar R, Boodhna T, et al. Eradicating primary congenial glaucoma for Saudi Arabia. The
case for a national screening program. Saudi J Ophthalmol. 2017; 31 (4): 247-249.
5.
Beauchamp GR, Parks MM. Filtering surgery in children. Barriers to success.
Ophthalmology. 1979; 86: 170-180.
6.
Cadera W, Pachtman M.
Filtering surgery in childhood glaucoma, Ophthalmic Surg. 1984; 15: 319-322.
7.
Shaffer RN.
Prognosis of goniotomy in primary infantile glaucoma (trabeculodysgenesis)
Trans Am Ophthalmol Soc. 1982; 26: 321-325.
8.
McPherson SD, Jr, McFarland D. External trabeculectomy for developmental glaucoma.
Ophthalmology, 1980; 87: 302-305.
9.
Dietlein TS, Jacobi PC, Krieglstein GK. Prognosis of primary ab externo surgery for primary congenital
glaucoma. Br J Ophthalmol. 1999; 83: 174-179.
10.
Mendal AK, Walton DS, John T, Jayagandan A. Mitomycin C – augmented trabeculectomy in refractory congenital
glaucoma. Ophthalmology, 1997; 104: 996-1001.
11.
Girkin CA, Rhodes L, McGwin G, Marchase N, Cogen MS. Goniotomy versus circumferential trabeculotomy with an
illuminated microcatheter in congenital glaucoma. J AAPOS. 2012; 16: 424-427.
12.
Mendicino ME, Lynch MG, Drack A, Beck AD, Harbin T, Pollard Z, et
al. Long-term surgical and visual
outcome in primary congenital glaucoma: 360 degree trabeculotomy versus
goniotomy. J AAPOS. 2000; 4: 205-210.
13.
Beck AD, Lynn MJ, Crandall J, Mobin-Uddin O. Surgical outcomes with 360-degree suture trabeculotomy in
poor-prognosis primary congenital glaucoma and glaucoma associated with
congenital anomalies or cataract surgery. J AAPOS. 2011; 15: 54-58.
14.
Mahar PS, Memon AS, Bukhari S, Bhutto IA. Outcome of Mitomycin – C augmented Trabeculectomy in primary
congenital glaucoma. Pak J Ophthalmol. 2012; 28 (3): 136-139.
15.
Molteno A.
Children with advanced glaucoma treated by draining implants. S Afr Arch
Ophthalmol. 1973; 1: 55-62.
16.
EI Sayed Y, Awadein A.
Polypropylene vs Silicone Ahmed valve with adjunctive Mitomycin C in Pediatric
age group: A prospective controlled study. Eye, 2013; 27: 728-734.
17.
Ishida K, Mandal AK, Netland PA. Glaucoma drainage implants in pediatric patients. Ophthalmol Clin
North Am. 2005; 18: 431-442.
18.
Al-Mobarak F, Khan AO.
Two-year survival of Ahmed valve implantation in the first 2 years of life with
and without intraoperative Mitomycin – C. Ophthalmology, 2009; 116: 1862-1865.
19.
Tsai JC, Grajewski Al, Parrish RK. Surgical revision of glaucoma shunt implants. Ophthalmic Surg
Lasers, 1999; 30: 40-46.